Saransh Chaudhary
-
Venus Remedies secures regulatory approvals for three key oncology drugs in Ukraine
Ukrainian has given marketing approvals for paclitaxel, oxaliplatin and irinotecan Venus Remedies has further expanded the reach of its oncology…
Read More » -
Venus Remedies bags first incentive of Rs7.50 Cr under PLI scheme
The disbursement will bolster the company’s manufacturing capabilities and foster product diversification, including complex generics Venus Remedies has been awarded…
Read More » -
Venus Remedies gets coveted GMP certification from Libya
The GMP certification for the company’s production facilities has added to its portfolio of international approvals from 25 regulators Venus…
Read More » -
Venus Remedies bags market authorisation for Bleomycin 15,000 IU in UK
Bleomycin 15,000 IU is a potent medication that contains the active ingredient bleomycin sulfate, specifically designed to combat cancer Venus…
Read More » -
Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines
Venus Remedies’ oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug Venus Remedies has received marketing…
Read More » -
Venus Remedies bags Saudi marketing approval for Enoxaparin in PFS
The company expects this marketing approval to enable it to rapidly expand its operations not only in Saudi Arabia, the…
Read More » -
Venus Remedies bags approval to market Meropenem in Spain
The company has secured more than 120 marketing authorisations for meropenem throughout the world Venus Remedies has achieved yet another…
Read More » -
Venus Remedies bags Ukrainian GMP approval for Carbapenem, oncology parenteral facilities
With Ukraine extending GMP to all seven facilities of Venus Remedies in Baddi, the company is looking to expand its…
Read More »